SYDNEY, Australia, April 3 /PRNewswire-FirstCall/ -- Ventracor Limited has announced recent management appointments to expand its global reach and to prepare for the anticipated market launch of the VentrAssist in Europe.
Charles S. Love has been appointed Vice President, Clinical and Regulatory Affairs, and will be based in the Company’s California office. He has over 15 years of experience in Class III Medical devices, including founding two companies in the cardiac surgery field, and has over 20 US patents. Chuck is well versed in the engineering, business, clinical and regulatory issues in bringing a complex medical device to the world market.
Pascal Barrier has been appointed Director, European Operations. His most recent role was with Medtronic Europe (http://www.medtronic.com ) as Key Accounts Manager for Heart Valves. Pascal is educated in biomedical engineering and business. He has several years experience in technical support and business development in cardiac surgery products. He will be based in France and is responsible for field support and market development in Europe.
Robert Varnier has been recruited to help build the European business, concentrating initially on developing the French market for the VentrAssist. Robert has a degree in international business and marketing and more than 14 years experience in sales including 10 selling cardiovascular products. He was recently Territory Manager in France for Thoratec (http://www.thoratec.com ) where he introduced LVADs to most of the country’s transplant centres.
Jennifer Braaten was recently Clinical Affairs Specialist for Baxter Edwards (http://www.baxter.com ) in Europe, coordinating clinical studies for the Cardiovascular Surgery Division. She will be based in Zurich and will provide training and field technical support for implants in Europe with an emphasis on Northern Europe.
About Ventracor
Ventracor is a global medical device company that has developed a blood pump, the VentrAssist left ventricular assist device (LVAD) for patients in heart failure. Ventracor plans to bring the VentrAssist to the global market.
For further information, please contact: Andrew Geddes Manager, Investor Relations Ventracor Limited T: + 61 2 9406 3086 E: info@ventracor.comhttp://www.ventracor.com
Ventracor Limited
CONTACT: Andrew Geddes, Manager, Investor Relations, of Ventracor Limited,+61-2-9406-3086, info@ventracor.com
